About Bone Marrow
Bone marrow is a rich source of both adult stem and progenitor cells. Marrow-derived stem cells have been utilized extensively for over 40 years in the field of bone marrow transplantation, primarily for the treatment of a wide array of cancers and hematologic diseases for which over 60,000 transplants are performed each year. Orthopedic procedures, such as spinal fusions and the treatment of non-union fractures, also commonly utilize the patient's own bone marrow. More recently, marrow-derived cells are showing promise in the treatment of a widening array of diseases and conditions.
About Regenerative Medicine
Regenerative medicine focuses on the ability to repair or regenerate damaged, diseased or aging tissues, and is rapidly emerging as the next frontier in medicine. Regenerative therapies have the potential to provide effective treatment for millions of patients worldwide suffering from a wide array of diseases, including cardiovascular, endocrine (i.e. diabetes), neurologic, and orthopedic diseases. A critical aspect of many regenerative therapies is the ability to utilize the patient's own stem and progenitor cells, requiring the harvest, processing, and delivery of these cells to a target organ.
StemCor Systems is a privately held medical device company located in
the San Francisco Bay Area developing enabling technologies for
regenerative medicine. The company's initial product is the MarrowMiner, a
proprietary, minimally-invasive bone marrow collection system. The
technology was invented by Daniel Kraft, MD, and was licensed exclusively
from Stanford University. Clinical studies are now underway to evaluate the
potential of the MarrowMiner System to obtain sufficient and hi
|SOURCE StemCor Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved